PCDH20 functions as a tumour‐suppressor gene through antagonizing the Wnt/β‐catenin signalling pathway in hepatocellular carcinoma (English)
- New search for: Lv, J.
- New search for: Zhu, P.
- New search for: Yang, Z.
- New search for: Li, M.
- New search for: Zhang, X.
- New search for: Cheng, J.
- New search for: Chen, X.
- New search for: Lu, F.
- New search for: Lv, J.
- New search for: Zhu, P.
- New search for: Yang, Z.
- New search for: Li, M.
- New search for: Zhang, X.
- New search for: Cheng, J.
- New search for: Chen, X.
- New search for: Lu, F.
In:
Journal of Viral Hepatitis
;
22
, 2
;
199-209
;
2015
- Article (Journal) / Electronic Resource
-
Title:PCDH20 functions as a tumour‐suppressor gene through antagonizing the Wnt/β‐catenin signalling pathway in hepatocellular carcinoma
-
Contributors:
-
Published in:Journal of Viral Hepatitis ; 22, 2 ; 199-209
-
Publisher:
-
Publication date:2015-02-01
-
Size:11 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 22, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 75
-
Treating Immune‐tolerant Hepatitis BTseng, T.‐C. / Kao, J.‐H. et al. | 2015
- 83
-
Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trialHou, J. L. / Gao, Z. L. / Xie, Q. / Zhang, J. M. / Sheng, J. F. / Cheng, J. / Chen, C. W. / Mao, Q. / Zhao, W. / Ren, H. et al. | 2015
- 92
-
Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis BYasui, S. / Fujiwara, K. / Nakamura, M. / Miyamura, T. / Yonemitsu, Y. / Mikata, R. / Arai, M. / Kanda, T. / Imazeki, F. / Oda, S. et al. | 2015
- 101
-
Seroprevalence of occult hepatitis B among Egyptian paediatric hepatitis C cancer patientsRaouf, H. E. / Yassin, A. S. / Megahed, S. A. / Ashour, M. S. / Mansour, T. M. et al. | 2015
- 110
-
Aberrant DNA methylation of G‐protein‐coupled bile acid receptor Gpbar1 predicts prognosis of acute‐on‐chronic hepatitis B liver failureGao, S. / Ji, X.‐F. / Li, F. / Sun, F.‐K. / Zhao, J. / Fan, Y.‐C. / Wang, K. et al. | 2015
- 118
-
Hepatocellular carcinoma risk in HBeAg‐negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohortPapatheodoridis, G. V. / Manolakopoulos, S. / Touloumi, G. / Nikolopoulou, G. / Raptopoulou‐Gigi, M. / Gogos, C. / Vafiadis‐Zouboulis, I. / Karamanolis, D. / Chouta, A. / Ilias, A. et al. | 2015
- 126
-
Serum microRNA‐124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infectionWang, J.‐Y / Mao, R.‐C / Zhang, Y.‐M / Zhang, Y.‐J / Liu, H.‐Y / Qin, Y.‐L / Lu, M.‐J / Zhang, J.‐M et al. | 2015
- 135
-
Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United StatesYounossi, Z. M. / Otgonsuren, M. / Henry, L. / Arsalla, Z. / Stepnaova, M. / Mishra, A. / Venkatesan, C. / Hunt, S. et al. | 2015
- 144
-
Hepatic expression of miR‐122, miR‐126, miR‐136 and miR‐181a and their correlation to histopathological and clinical characteristics of patients with hepatitis CBoštjančič, E. / Bandelj, E. / Luzar, B. / Poljak, M. / Glavač, D. et al. | 2015
- 156
-
Emergence of resistant variants detected by ultra‐deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1Kosaka, K. / Imamura, M. / Hayes, C. N. / Abe, H. / Hiraga, N. / Yoshimi, S. / Murakami, E. / Kawaoka, T. / Tsuge, M. / Aikata, H. et al. | 2015
- 164
-
Ribavirin dose reduction during telaprevir/ribavirin/peg‐interferon therapy overcomes the effect of the ITPA gene polymorphismAkamatsu, S. / Hayes, C. N. / Tsuge, M. / Murakami, E. / Hiraga, N. / Abe, H. / Miki, D. / Imamura, M. / Ochi, H. / Chayama, K. et al. | 2015
- 173
-
Management of treatment‐naïve chronic hepatitis C genotype 1 patients: a cost‐effectiveness analysis of treatment optionsCortesi, P. A. / Ciaccio, A. / Rota, M. / Lim, J. K. / De Salvia, S. / Okolicsanyi, S. / Vinci, M. / Belli, L. S. / Mantovani, L. G. / Strazzabosco, M. et al. | 2015
- 182
-
rs2230201 polymorphism may dictate complement C3 levels and response to treatment in chronic hepatitis C patientsChowdhury, S. J. / Karra, V. K. / Gumma, P. K. / Bharali, R. / Kar, P. et al. | 2015
- 190
-
Predictive value of serum actin‐free Gc‐globulin for complications and outcome in acute liver failureBagchi, A. / Kumar, S. / Ray, P. C. / Das, B. C. / Gumma, P. K. / Kar, P. et al. | 2015
- 199
-
PCDH20 functions as a tumour‐suppressor gene through antagonizing the Wnt/β‐catenin signalling pathway in hepatocellular carcinomaLv, J. / Zhu, P. / Yang, Z. / Li, M. / Zhang, X. / Cheng, J. / Chen, X. / Lu, F. et al. | 2015
- i
-
Issue Information| 2015